Home | Symbol Index | About |
Crucell (CRXL.AS)
Crucell is related to 1 other symbol. To date we've encountered releases involving Crucell.
Last Price: 16.495 (+4.915) - 1/8/2009,
11:38am
- Open: 15.64
- High: 16.50
- Low: 15.155
Crucell Options
Crucell "Business Partners"
A "business partner" is defined as a third party company that has co-released at least one press release with Crucell.
^
Crucell Press Releases
- We have not detected any press releases (via MarketWire) yet.
^
Crucell News
- Crucell and Wyeth in Discussion on a Combination of the Two Companies (Marketwire), Wed, 7 Jan 2009 21:45:00 Etc/GMT
- Crucell Announces STAR(R) Research and Commercial License Agreement with Centocor, Inc. (Marketwire), Tue, 6 Jan 2009 07:05:00 Etc/GMT
- DSM and Crucell Announce PER.C6(R) License Agreement with CSL Ltd. (Marketwire), Thu, 18 Dec 2008 13:12:00 Etc/GMT
- DSM and Crucell Announce PER.C6(R) Research License Agreement with GSK (Marketwire), Thu, 18 Dec 2008 07:00:00 Etc/GMT
- Crucell Signs Second Exclusive License Agreement with Talecris Biotherapeutics (Marketwire), Wed, 17 Dec 2008 13:11:00 Etc/GMT
- Crucell Announces Excellent Results for Influenza Antibody (Marketwire), Thu, 11 Dec 2008 07:00:00 Etc/GMT
- Crucell Announces Registration of Hepavax-Gene(R) in China (Marketwire), Mon, 8 Dec 2008 06:53:00 Etc/GMT
- DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter (Marketwire), Tue, 25 Nov 2008 06:53:00 Etc/GMT
- Crucell Announces Third Quarter 2008 Results (Marketwire), Tue, 11 Nov 2008 06:58:00 Etc/GMT
- Crucell to Release Q3 2008 Earnings on Tuesday, November 11, 2008 (Marketwire), Tue, 4 Nov 2008 13:00:00 Etc/GMT
- Crucell Doubles Production of Quinvaxem(R) in 2008 and Prepares Move to New Korean Production Site to Facilitate Growth (Marketwire), Tue, 21 Oct 2008 10:10:00 Etc/GMT
- Aeras and Crucell Announce TB Vaccine Clinical Trial in Kenya; Promising Vaccine Candidate Advances to Phase II Safety Study in South Africa (Marketwire), Fri, 17 Oct 2008 05:50:00 Etc/GMT
- Crucell Receives NIAID/NIH Contract for Development of Ebola and Marburg Vaccines (Marketwire), Fri, 3 Oct 2008 08:00:00 Etc/GMT
- Crucell Announces Positive Results of Phase II Clinical Study Rabies Monoclonal Antibody Combination in US (Marketwire), Wed, 1 Oct 2008 19:39:00 Etc/GMT
- DSM and Crucell announce another key achievement for PER.C6(R) Technology; Scale up of high-titer Fed-Batch Process to 250 Liters (Marketwire), Mon, 29 Sep 2008 12:05:00 Etc/GMT
- Crucell's Swiss Affiliate Berna Biotech to Cease All Animal Testing (Marketwire), Fri, 26 Sep 2008 05:45:00 Etc/GMT
- Lonza and Crucell enter into long term agreement (Marketwire), Thu, 25 Sep 2008 05:35:00 Etc/GMT
- New contracts awarded for Quinvaxem(R) and Hepavax-Gene(R) (Marketwire), Tue, 23 Sep 2008 05:50:00 Etc/GMT
- Crucell Signs Exclusive License Agreement with Talecris Biotherapeutics (Marketwire), Thu, 18 Sep 2008 05:51:00 Etc/GMT
- Crucell to move Dukoral(R) and rCTB bulk production, formulation and fill/finish activities from Sweden to other sites (Marketwire), Tue, 26 Aug 2008 12:59:00 Etc/GMT
^
Crucell Contact
- We have not detected any contact information yet.
- TRYNT did not suggest any related symbols
^
What is a Stock Cloud?
A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.